Decrease in growth hormone and insulin-like growth factor (IGF)-1 release and amelioration of acromegaly features after rosiglitazone treatment of type 2 diabetes mellitus a patient with acromegaly
about
Bone loss in diabetes: use of antidiabetic thiazolidinediones and secondary osteoporosis.Assessing the benefits of rosiglitazone in women with polycystic ovary syndrome through its effects on insulin-like growth factor 1, insulin-like growth factor-binding protein-3 and insulin resistance: a pilot studyRosiglitazone as an option for patients with acromegaly: a case series.
P2860
Decrease in growth hormone and insulin-like growth factor (IGF)-1 release and amelioration of acromegaly features after rosiglitazone treatment of type 2 diabetes mellitus a patient with acromegaly
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Decrease in growth hormone and ...... itus a patient with acromegaly
@ast
Decrease in growth hormone and ...... itus a patient with acromegaly
@en
type
label
Decrease in growth hormone and ...... itus a patient with acromegaly
@ast
Decrease in growth hormone and ...... itus a patient with acromegaly
@en
prefLabel
Decrease in growth hormone and ...... itus a patient with acromegaly
@ast
Decrease in growth hormone and ...... itus a patient with acromegaly
@en
P2093
P2860
P1476
Decrease in growth hormone and ...... itus a patient with acromegaly
@en
P2093
Marina Gradiser
Martina Matovinovic
Milan Vrkljan
P2860
P577
2007-02-01T00:00:00Z